Scandinavian ChemoTech AB Logo

Scandinavian ChemoTech AB

CMOTEC | ST

Overview

Corporate Details

ISIN(s):
SE0009242654 (+1 more)
LEI:
549300CDVAKAUH9D5Z69
Country:
Sweden
Address:
C/O Medicon Village, 223 63 Lund
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Scandinavian ChemoTech AB is a medical technology company developing and marketing innovative solutions for cancer treatment in humans and animals. The company's core is its patented Tumour Specific Electroporation™ (TSE) technology, a platform designed to enhance the efficacy of low-dose chemotherapy. TSE works by creating a dynamic electric field that increases tumour cell permeability while preserving healthy tissue by promoting apoptosis (programmed cell death) over ablation. Its flagship product, IQwave™, is a CE-marked device used to treat solid tumours, particularly those in sensitive areas or resistant to conventional therapies. The company focuses on providing cost-effective treatment alternatives, with a primary human care market focus on India, Asia, and the Middle East.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Scandinavian ChemoTech AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Scandinavian ChemoTech AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Scandinavian ChemoTech AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Theradiag Logo
Develops IVD tests for biotherapy monitoring in autoimmune diseases and oncology.
France ALTER
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
Developing disruptive spinal fixation devices for the vertebral surgery market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
Global provider of medical devices and genetic testing services for the IVF treatment journey.
Sweden VITR
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO
Ypsomed Holding AG Logo
Develops injection systems for self-medication, partnering with pharma and biotech firms.
Switzerland YPSN